Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Xolair shows Real-World promise for stubborn nasal polyps

NCT ID NCT05626257

First seen Nov 21, 2025 · Last updated May 25, 2026 · Updated 17 times

Summary

This study checked how safe and effective Xolair is for adults with chronic sinusitis and nasal polyps that don't get better with standard treatments. It included 135 people in routine medical care. The main goal was to track side effects, and the study also measured how symptoms affect quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Novartis Investigative Site

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Novartis Investigative Site

    Bundang Gu, Gyeonggi-do, 13620, South Korea

  • Novartis Investigative Site

    Uijeongbu-si, Gyeonggi-do, 11759, South Korea

  • Novartis Investigative Site

    Incheon, Korea, 405 760, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 03080, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 03312, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 07061, South Korea

  • Novartis Investigative Site

    Seoul, Korea, 08308, South Korea

  • Novartis Investigative Site

    Seoul, Yangcheon gu, 07985, South Korea

  • Novartis Investigative Site

    Daegu, 705 718, South Korea

  • Novartis Investigative Site

    Gyeonggi-do, 14353, South Korea

  • Novartis Investigative Site

    Seoul, 03722, South Korea

  • Novartis Investigative Site

    Seoul, 06351, South Korea

  • Novartis Investigative Site

    Seoul, 07804, South Korea

  • Novartis Investigative Site

    Seoul, 2447, South Korea

  • Novartis Investigative Site

    Suwon, 16247, South Korea

Conditions

Explore the condition pages connected to this study.